Fresenius Medical Care AG & Co. KGaA

FMS • Medical - Care Facilities

$22.66

▲ +0.19 (+0.85%)

Precio actual

ResultadosÚltimo reporte: 30 jun 2026

PERFIL FAVORABLEAtractivaConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Perfil sólido con apoyo razonable de valoración. Los datos sugieren una combinación equilibrada entre calidad y precio.

Capitalización

$12.47B

Crecimiento

5.7%

Flujo de caja

5/5

Tendencia

Stable

Evidencia

Crecimiento positivo de ingresos · 22.4%Flujo de caja libre positivo · 2.91Flujo de caja libre consistente · 5/5Múltiplo de ganancias razonable · 12.07Nivel de deuda manejable · 0.76

Datos financieros hasta: 30 jun 2026, 12:00 a.m. UTCÚltima actualización de earnings: 30 jun 2026, 12:00 a.m. UTCÚltima actualización del perfil: 6 ago 2026, 1:37 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$22.66

Change0.85%

Shares Out550.44M

Market Cap$12.47B

52W Range20.02 - 27.64

Beta0.76

P/E21.35

P/S2.18

P/B0.76

P/FCF272.54

EV/Sales4.45

EV/EBITDA26.89

Price$22.66

Change0.85%

Shares Out550.44M

Market Cap$12.47B

52W Range20.02 - 27.64

Beta0.76

P/E21.35

P/S2.18

P/B0.76

P/FCF272.54

EV/Sales4.45

EV/EBITDA26.89

EV/FCF557.67

Earnings Yield4.68%

FCF Yield0.37%

Dividend Yield0.00%

Gross Margin25.62%

Oper. Margin9.31%

Profit Margin4.98%

Debt/Eq0.76

Current Ratio1.26

Quick Ratio0.92

Revenue 5Y5.75%

Target$23.57

Target Upside4.02%

Target Median$25.00

Target Range19.90 - 25.80

Volume56.78K

Avg Volume780.67K

EPS Surprise-0.06

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

47/100

Fortaleza financiera

Deuda, caja, estabilidad

64/100

Potencial de crecimiento

Ingresos y expansión

95/100

Atractivo del precio

Barata o cara hoy

93/100

Por qué este puntaje▼

Crecimiento positivo de ingresos · 22.4%Flujo de caja libre positivo · 2.91Flujo de caja libre consistente · 5/5Múltiplo de ganancias razonable · 12.07Nivel de deuda manejable · 0.76

Analyst view

Analyst sentiment and price target

FMS

Analyst sentiment

Based on 21 analyst votes · 2026-09-05

57/100

Neutral

Bullish

Hold

Bearish

Precio objetivo

2026-08-06

Bajo

$19.90

Promedio

$22.45

Mediana

$22.45

Alto

$25.00

Resumen de la compañía

IPO: 9/17/1996

Industria: Medical - Care Facilities

P/B i: 0.76

Deuda / Patrimonio i: 0.76

Margen operativo: 9.31%

Margen neto: 4.98%

ROE i: -

ROIC: -

Salud financiera

Puntaje13 / 20

Deuda / Patrimonio: 0.76

Ratio corriente: 1.26

Ratio rápido: 0.92

Estado: Good

Transacciones internas

Actividad reciente de ejecutivos e insiders

Renkewitsch Olga

Transacción: 03/18/2026

OTRO

Cambio

Precio

Not reported

Presentación

03/18/2026

Tipo

OTRO

Insider	Tipo	Cambio	Precio	Transacción	Presentación
Renkewitsch Olga	OTRO	0	Not reported	03/18/2026	03/18/2026

Sobre la compañía

Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co. KGaA specializes in comprehensive kidney dialysis treatment and associated services, operating across Germany, North America, and numerous international territories. Through an extensive network of outpatient clinics, it delivers essential dialysis therapy along with laboratory and diagnostic support. For home-based care, the company supplies necessary equipment, provides comprehensive training, and offers ongoing patient assistance, including clinical oversight and coordinating supply deliveries directly to patients. In the United States, Fresenius Medical Care also contracts with hospitals to provide vital dialysis interventions for hospitalized individuals suffering from end-stage renal disease (ESRD) and acute kidney failure. Beyond services, it is a prominent developer, manufacturer, and distributor of a broad range of dialysis products. This portfolio encompasses polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers and solutions, concentrates, bloodlines, renal pharmaceuticals, and water treatment systems. Additionally, the company produces non-dialysis medical devices, including acute cardiopulmonary and apheresis products. Its pharmaceutical division focuses on developing, acquiring, and in-licensing specialized renal medications, distributing these essential drugs and supplies to both individual patients' homes and dialysis centers. The company also extends its medical offerings to include a variety of specialized services such as vascular, cardiovascular, and endovascular care, operating ambulatory surgery centers for vascular procedures, and providing physician services in nephrology and cardiology. Products are sold directly to dialysis clinics, hospitals, and specialized treatment centers, complemented by sales through local teams, independent distributors, dealers, and agents. By February 23, 2022, Fresenius Medical Care managed an impressive network of 4,171 outpatient dialysis clinics across roughly 150 countries. Established in 1996, the company maintains its headquarters in Bad Homburg, Germany.

Fuente - Link

Competidores

DVA EHC HOLX ICLR RPRX SNN SOLV TEM THC UHS

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

Can Fresenius Medical's 5008X Rollout Drive the Next Growth Phase?

Fresenius Medical is scaling its 5008X rollout across U.S. clinics, creating growth potential despite volume, reimbursement and rollout-cost pressures.

Zacks Investment Research

Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now

Fresenius Medical's improving profitability, 5008X rollout and value-based care gains offer support despite volume and reimbursement risks.

Zacks Investment Research

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Share Price Passes Above 200 Day Moving Average – Time to Sell?

Fresenius Medical Care AG and Co. KGaA (NYSE: FMS - Get Free Report) shares passed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $23.13 and traded as high as $23.92. Fresenius Medical Care AG and Co. KGaA shares last traded at $23.43,

Defense World

3 Cheap International Stocks to Buy

These stocks have economic moats and look attractive today.

Morningstar

Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights

Fresenius Medical Care AG and Co. KGaA (NYSE: FMS) reported second-quarter 2026 organic revenue growth of 5% and a 23% increase in operating income at constant currency, while confirming its full-year outlook despite weaker U.S. treatment volumes and anticipated reimbursement-related headwinds in the second half. Chief Executive Officer Helen Giza said the company's operating-income growth accelerated

Defense World

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-05-05	0.59	0.53	-0.06
2026-02-24	0.647	0.83	0.183
2025-11-04	0.59	0.64	0.05
2025-08-05	0.5	0.52	0.02
2025-05-06	0.43	0.44	0.01
2025-02-25	0.41	0.48	0.07
2024-11-05	0.38	0.45	0.07
2024-07-30	0.38	0.38	0
2024-05-07	0.26	0.36	0.1
2024-02-20	0.36	0.47	0.11
2023-11-01	0.31	0.28	-0.03
2023-08-02	0.24	0.32	0.08